Infanrix™ IPV

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bNeisseria MeningitidisPoliomyelitisTetanus

Phase 3

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

CompletedNCT00586612

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2007-12-01End: 2008-12-30Updated: 2018-08-27

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

CompletedNCT01309646

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +2

Start: 2011-03-04End: 2012-02-24Updated: 2019-11-27

Related Papers

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study

Human Vaccines & Immunotherapeutics2018-11-155 citations